There raising claim that new drugs do not receive a reasonable price in the process of registering domestic new drug list
Pharmaceutical manufacturers industry is claiming that due to the institutional irrationalism, there are increasing cases which get an unkind treatment in the process of registering domestic new drug list. They explained that there is problem on the process of registering domestic new drug list, ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
